Published in J Mol Evol on January 28, 2015
Molecular Evolution of the TET Gene Family in Mammals. Int J Mol Sci (2015) 0.75
Mechanistic insights into molecular evolution of species-specific differential glycosaminoglycan binding surfaces in growth-related oncogene chemokines. R Soc Open Sci (2017) 0.75
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol (1987) 266.90
MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol (2011) 220.97
New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol (2010) 53.37
PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol (2007) 45.68
Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A (2001) 42.14
jModelTest 2: more models, new heuristics and parallel computing. Nat Methods (2012) 27.83
I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc (2010) 22.66
Recent developments in the MAFFT multiple sequence alignment program. Brief Bioinform (2008) 22.07
I-TASSER server for protein 3D structure prediction. BMC Bioinformatics (2008) 18.28
Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics (2000) 14.84
Bayes empirical bayes inference of amino acid sites under positive selection. Mol Biol Evol (2005) 11.26
Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics (1998) 11.25
CONFIDENCE LIMITS ON PHYLOGENIES: AN APPROACH USING THE BOOTSTRAP. Evolution (1985) 10.10
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med (1998) 8.62
The Ensembl core software libraries. Genome Res (2004) 7.30
Large-scale search for genes on which positive selection may operate. Mol Biol Evol (1996) 6.14
The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol Pharmacol (2005) 4.07
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev (2009) 3.65
The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J Immunol (1975) 3.50
Formyl-peptide receptors revisited. Trends Immunol (2002) 3.08
Codon-substitution models to detect adaptive evolution that account for heterogeneous selective pressures among site classes. Mol Biol Evol (2002) 2.77
Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors. Nature (2009) 2.63
CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS One (2010) 2.28
Formyl peptide receptors are candidate chemosensory receptors in the vomeronasal organ. Proc Natl Acad Sci U S A (2009) 2.11
Modeling the site-specific variation of selection patterns along lineages. Proc Natl Acad Sci U S A (2004) 1.82
The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. Pharmacol Ther (1997) 1.39
Integration of virtual screening with high-throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists. Mol Pharmacol (2005) 1.37
Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils. J Immunol (2008) 1.30
Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease. J Leukoc Biol (2002) 1.26
Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. Construction and analysis of chimeric N-formyl peptide receptors. J Biol Chem (1993) 1.21
The GRAFS classification system of G-protein coupled receptors in comparative perspective. Gen Comp Endocrinol (2005) 1.16
G protein-coupled time travel: evolutionary aspects of GPCR research. Mol Interv (2007) 1.16
Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. J Exp Med (2004) 1.14
Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2. J Immunol (2004) 1.01
Characterization of the binding site on the formyl peptide receptor using three receptor mutants and analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu. J Biol Chem (2000) 0.98
Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury? Trends Pharmacol Sci (2010) 0.97
Rapid evolution by positive Darwinian selection in T-cell antigen CD4 in primates. J Mol Evol (2008) 0.96
Functional characterization of three mouse formyl peptide receptors. Mol Pharmacol (2012) 0.95
Chemokine scavenging by D6: a movable feast? Trends Immunol (2006) 0.92
Performance of standard and stochastic branch-site models for detecting positive selection among coding sequences. Mol Biol Evol (2013) 0.87
N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation. J Biol Chem (2011) 0.86
Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1. J Mol Model (2011) 0.85
Expansion of the superfamily of G-protein-coupled receptors in chordates. Ann N Y Acad Sci (2005) 0.85
Molecular evolution of the N-formyl peptide and C5a receptors in non-human primates. Immunogenetics (1996) 0.84
Signatures of natural selection in a primate bitter taste receptor. J Mol Evol (2012) 0.84
Diversifying and purifying selection in the peptide binding region of DRB in mammals. J Mol Evol (2008) 0.84
Induction of macrophage migration by neurotoxic prion protein fragment. J Neurosci Methods (2009) 0.81
Mechanism of the protective effect of intraperitoneally administered agonists for formyl peptide receptors against chemotherapy-induced alopecia. Biosci Biotechnol Biochem (2007) 0.80
Molecular and evolutionary analyses of formyl peptide receptors suggest the absence of VNO-specific FPRs in primates. J Genet Genomics (2010) 0.79
Stimulation of human formyl peptide receptors by calpain inhibitors: homology modeling of receptors and ligand docking simulation. Arch Biochem Biophys (2011) 0.79
Transcriptional variations mediated by an alternative promoter of the FPR3 gene. Mamm Genome (2011) 0.75
SeaView version 4: A multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol Biol Evol (2009) 21.24
Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med (2004) 2.71
TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade. Proc Natl Acad Sci U S A (2009) 2.20
Dental changes evaluated with a 3D computer-assisted model analysis after long-term tongue retaining device wear in OSA patients. Sleep Breath (2008) 2.02
Epigenetic gene silencing underlies C-fiber dysfunctions in neuropathic pain. J Neurosci (2010) 1.31
Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J Pharmacol Exp Ther (2003) 1.30
Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin. J Pharmacol Exp Ther (2006) 1.24
Oral health, general health, and quality of life in older people. Spec Care Dentist (2008) 1.24
Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation. J Biol Chem (2009) 1.17
Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception. Proc Natl Acad Sci U S A (2002) 1.14
Urban poverty: an urgent public health issue. J Urban Health (2007) 1.14
Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain. Mol Pain (2008) 1.13
TRPM1: a vertebrate TRP channel responsible for retinal ON bipolar function. Cell Calcium (2010) 1.13
Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus. FASEB J (2002) 1.12
Locus-specific rescue of GluRepsilon1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J Neurosci (2003) 1.12
Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain. J Pharmacol Exp Ther (2004) 1.11
Morphine-induced chemotaxis and brain-derived neurotrophic factor expression in microglia. J Neurosci (2005) 1.07
Olfactory imprinting of amino acids in lacustrine sockeye salmon. PLoS One (2010) 1.00
Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine. Mol Pain (2010) 1.00
Increased expression of vanilloid receptor 1 on myelinated primary afferent neurons contributes to the antihyperalgesic effect of capsaicin cream in diabetic neuropathic pain in mice. J Pharmacol Exp Ther (2003) 0.99
Characterization of three different sensory fibers by use of neonatal capsaicin treatment, spinal antagonism and a novel electrical stimulation-induced paw flexion test. Mol Pain (2006) 0.97
"Quenchbodies": quench-based antibody probes that show antigen-dependent fluorescence. J Am Chem Soc (2011) 0.96
Noncompetitive detection of low molecular weight peptides by open sandwich immunoassay. Anal Chem (2007) 0.96
Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism. Brain Res (2002) 0.96
Emerging functions for tuberoinfundibular peptide of 39 residues. Trends Endocrinol Metab (2003) 0.96
Switching of bradykinin-mediated nociception following partial sciatic nerve injury in mice. J Pharmacol Exp Ther (2003) 0.95
Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain. J Pharmacol Exp Ther (2010) 0.95
Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain. Mol Pain (2009) 0.95
Pharmacological switch in Abeta-fiber stimulation-induced spinal transmission in mice with partial sciatic nerve injury. Mol Pain (2008) 0.95
Chaperone-assisted folding of a single-chain antibody in a reconstituted translation system. Biochem Biophys Res Commun (2004) 0.94
Cyclic RGD peptide-labeled upconversion nanophosphors for tumor cell-targeted imaging. Biochem Biophys Res Commun (2009) 0.94
Nasal pressure recordings to detect obstructive sleep apnea. Sleep Breath (2006) 0.93
LPA-mediated demyelination in ex vivo culture of dorsal root. Neurochem Int (2006) 0.92
NSAID zaltoprofen possesses novel anti-nociceptive mechanism through blockage of B2-type bradykinin receptor in nerve endings. Neurosci Lett (2006) 0.91
The algogenic-induced nociceptive flexion test in mice: studies on sensitivity of the test and stress on animals. Brain Res Bull (2003) 0.91
The influence of rate heterogeneity among sites on the time dependence of molecular rates. Mol Biol Evol (2012) 0.91
Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia. Mol Pain (2008) 0.90
Antinociceptive effect of cyclic phosphatidic acid and its derivative on animal models of acute and chronic pain. Mol Pain (2011) 0.90
Tonic inhibitory role of alpha4beta2 subtype of nicotinic acetylcholine receptors on nociceptive transmission in the spinal cord in mice. Pain (2006) 0.90
Importance of terminal residues on circularly permutated Escherichia coli alkaline phosphatase with high specific activity. J Biosci Bioeng (2005) 0.90
Necessity of lysophosphatidic acid receptor 1 for development of arthritis. Arthritis Rheum (2013) 0.89
Detection of protein-protein interaction by bioluminescence resonance energy transfer from firefly luciferase to red fluorescent protein. J Biosci Bioeng (2002) 0.89
Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist. J Neurochem (2009) 0.89
Possible mechanisms by which adipocyte lipolysis is enhanced in exercise-trained rats. Biochem Biophys Res Commun (2002) 0.89
Downregulation of P2X3 receptor-dependent sensory functions in A/J inbred mouse strain. Eur J Neurosci (2002) 0.88
Involvement of LPA1 receptor signaling in the reorganization of spinal input through Abeta-fibers in mice with partial sciatic nerve injury. Mol Pain (2008) 0.88
Open sandwich-based immuno-transistor for label-free and noncompetitive detection of low molecular weight antigen. Anal Chem (2009) 0.87
Performance of standard and stochastic branch-site models for detecting positive selection among coding sequences. Mol Biol Evol (2013) 0.87
In vivo pain-inhibitory role of nociceptin/orphanin FQ in spinal cord. J Pharmacol Exp Ther (2003) 0.87
Creation of a thermostable firefly luciferase with pH-insensitive luminescent color. Photochem Photobiol (2003) 0.87
Gi2 signaling enhances proliferation of neural progenitor cells in the developing brain. J Biol Chem (2004) 0.87
Human IgG1 expression in silkworm larval hemolymph using BmNPV bacmids and its N-linked glycan structure. J Biotechnol (2008) 0.86
Behavioral responses by migratory chum salmon to amino acids in natal stream water. Zoolog Sci (2009) 0.86
Calpain-mediated down-regulation of myelin-associated glycoprotein in lysophosphatidic acid-induced neuropathic pain. J Neurochem (2010) 0.86
Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin. FEBS J (2008) 0.86
Curcumin blocks chronic morphine analgesic tolerance and brain-derived neurotrophic factor upregulation. Neuroreport (2009) 0.86
EMG telemetry studies on upstream migration of chum salmon in the Toyohira River, Hokkaido, Japan. Fish Physiol Biochem (2011) 0.86
Detection of vimentin serine phosphorylation by multicolor Quenchbodies. Biosens Bioelectron (2012) 0.85
Life with and without heart disease among women and men over 50. J Women Aging (2008) 0.85
Profiling of BoNT/C3-reversible gene expression induced by lysophosphatidic acid: ephrinB1 gene up-regulation underlying neuropathic hyperalgesia and allodynia. Neurochem Int (2008) 0.85
Thoracoscopic esophagectomy and hand-assisted laparoscopic gastric mobilization for esophageal cancer with situs inversus totalis. J Gastrointest Surg (2011) 0.85
Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain. J Neurochem (2008) 0.85
Open-sandwich enzyme immunoassay for one-step noncompetitive detection of corticosteroid 11-deoxycortisol. Anal Chem (2009) 0.85
Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain. J Neurochem (2010) 0.85
Importance of a CDR H3 basal residue in V(H)/V(L) interaction of human antibodies. J Biochem (2002) 0.84
Identification of NF-kappaB responsive elements in follistatin related gene (FLRG) promoter. Gene (2007) 0.84
Loss of spinal substance P pain transmission under the condition of LPA1 receptor-mediated neuropathic pain. Mol Pain (2006) 0.84
Central administration of somatostatin stimulates feeding behavior in chicks. Gen Comp Endocrinol (2009) 0.84
Olfactory homing of chum salmon to stable compositions of amino acids in natal stream water. Zoolog Sci (2013) 0.84
Voltage-dependent N-type Ca2+ channel activity regulates the interaction between FGF-1 and S100A13 for stress-induced non-vesicular release. Cell Mol Neurobiol (2006) 0.84
Nocistatin and prepro-nociceptin/orphanin FQ 160-187 cause nociception through activation of Gi/o in capsaicin-sensitive and of Gs in capsaicin-insensitive nociceptors, respectively. J Pharmacol Exp Ther (2003) 0.84
Luminescent and substrate binding activities of firefly luciferase N-terminal domain. Biochim Biophys Acta (2003) 0.84
An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model. Mol Pain (2013) 0.84
Lysophosphatidic acid-induced membrane ruffling and brain-derived neurotrophic factor gene expression are mediated by ATP release in primary microglia. J Neurochem (2008) 0.84
Central administration of leucine, but not isoleucine and valine, stimulates feeding behavior in neonatal chicks. Neurosci Lett (2004) 0.83
Expression of smooth muscle cell-specific proteins in neural progenitor cells induced by agonists of G protein-coupled receptors and transforming growth factor-beta. J Neurochem (2007) 0.83
Demonstration of protein-fragment complementation assay using purified firefly luciferase fragments. BMC Biotechnol (2013) 0.83
The role of interface framework residues in determining antibody V(H)/V(L) interaction strength and antigen-binding affinity. FEBS J (2006) 0.83
Rapid homogeneous immunoassay of peptides based on bioluminescence resonance energy transfer from firefly luciferase. J Biosci Bioeng (2002) 0.83
Laboratory culture of the Oriental lancelet Branchiostoma belcheri. Zoolog Sci (2007) 0.83
The orexigenic effect of GnIH is mediated by central opioid receptors in chicks. Comp Biochem Physiol A Mol Integr Physiol (2008) 0.82
Structural basis for platelet antiaggregation by angiotensin II type 1 receptor antagonist losartan (DuP-753) via glycoprotein VI. J Med Chem (2010) 0.82
Seasonal changes of responses to gonadotropin-releasing hormone analog in expression of growth hormone/prolactin/somatolactin genes in the pituitary of masu salmon. Gen Comp Endocrinol (2003) 0.82
Bypassing antibiotic selection: positive screening of genetically modified cells with an antigen-dependent proliferation switch. Nucleic Acids Res (2003) 0.82
Novel type of Gq/11 protein-coupled neurosteroid receptor sensitive to endocrine disrupting chemicals in mast cell line (RBL-2H3). Br J Pharmacol (2005) 0.82
Permanent relief from intermittent cold stress-induced fibromyalgia-like abnormal pain by repeated intrathecal administration of antidepressants. Mol Pain (2011) 0.82
Identification of a Rho family specific guanine nucleotide exchange factor, FLJ00018, as a novel actin-binding protein. Cell Signal (2012) 0.82
HDAC inhibitors restore C-fibre sensitivity in experimental neuropathic pain model. Br J Pharmacol (2013) 0.82
Verification of a specific reaction between an airborne antigen and an immobilized antibody at a gas-solid interface. Anal Sci (2009) 0.81
A homogeneous noncompetitive immunoassay for the detection of small haptens. Anal Chem (2002) 0.81
Kinetics and binding sites for interaction of the prefoldin with a group II chaperonin: contiguous non-native substrate and chaperonin binding sites in the archaeal prefoldin. J Biol Chem (2004) 0.81
Absence of morphine analgesia and its underlying descending serotonergic activation in an experimental mouse model of fibromyalgia. Neurosci Lett (2010) 0.81
Single application of A2 NTX, a botulinum toxin A2 subunit, prevents chronic pain over long periods in both diabetic and spinal cord injury-induced neuropathic pain models. J Pharmacol Sci (2012) 0.81
Endocrine disrupting chemical atrazine causes degranulation through Gq/11 protein-coupled neurosteroid receptor in mast cells. Toxicol Sci (2005) 0.81
Evidence for the tonic inhibition of spinal pain by nicotinic cholinergic transmission through primary afferents. Mol Pain (2007) 0.81
A large cystic tumor with bile duct communication originating around the hepatic hilum. J Gastrointestin Liver Dis (2010) 0.81
Goniodomin A, an antifungal polyether macrolide, exhibits antiangiogenic activities via inhibition of actin reorganization in endothelial cells. J Cell Physiol (2002) 0.81
Seasonal changes in CRF-I and urotensin I transcript levels in masu salmon: correlation with cortisol secretion during spawning. Gen Comp Endocrinol (2007) 0.81
Improved growth response of antibody/receptor chimera attained by the engineering of transmembrane domain. Protein Eng Des Sel (2004) 0.80
Insulin receptor-protein kinase C-gamma signaling mediates inhibition of hypoxia-induced necrosis of cortical neurons. J Pharmacol Exp Ther (2005) 0.80